Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report
Neuro-Oncology · 14.10.2025 · 27 (9) · 2209-2224
DOI: 10.1093/neuonc/noaf118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 03.05.2025. Verfasst von Martin J van den Bent und 34 weiteren Autor:innen. Beteiligte Einrichtung: The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Medical Oncology, Clinical Trials as Topic, Outcome Assessment, Health Care, Central Nervous System Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Since its first activities in 2008 and 2009, the Response Assessment in NeuroOncology (RANO) group has given guidance on response assessment, trial design, and trial procedures to improve and standardize the way clinical trials in neurooncological studies are performed. To achieve its objectives, a variety of working groups have been initiated that cover many aspects of clinical trial design and outcome assessment in patients with tumors affecting the Central Nervous System. The RANO working groups are built on expertise without a formal structure, which makes rapid responses to new developments possible. RANO is aiming at evidence-based guidelines and recommendations, but in the absence of evidence will provide consensus-based guidance achieved by inviting recognized international experts. In its 15 years of existence, more than 60 RANO papers have been published mostly in high-ranking journals, and its recommendations have been accepted by regulators and industry as guiding principles. RANO organizes two meetings per year, one in conjunction with the annual American Society for Clinical Oncology (ASCO) meeting, and one during the annual Society for Neuro-Oncology meeting. These meetings are open, as are the working groups of RANO. New initiatives are welcomed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- Department of NeuroOncology, Moffitt Cancer Center, Tampa, Florida, USA.
- Department of Neurology, UCLA, California, USA.
- Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany.
- Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.
- Department of Neurology, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
ORCID-Profile: Martin J van den Bent, Tim Cloughesy, Norbert Galldiks, Nathalie L Albert, Joerg-Christian Tonn, Edward Avila, Jason Fangusaro, David Mirsky, Arjun Sahgal, Ricardo Soffietti, Philipp Karschnia, Minesh Mehta, Michelle M Kim, Florien Boele, Jason T Huse, Lakshmi Nayak, Mary Jane Lim-Fat, Emilie le Rhun, Annick Desjardins, Eudocia Q Lee, Ugonma Chukwueke, Johan A F Koekkoek, Tito Mendoza, Ashlee R Loughan, Joshua A Budhu, Spyridon Bakas, Raymond Y Huang, Javier E Villanueva-Meyer, Hideho Okada, David A Reardon, Wenya L Bi, Patrick Y Wen, Susan M Chang
Förderung
- NCI NIH HHS
- NINDS NIH HHS
Zitieren
APA
van den Bent, M. J., Vogelbaum, M. A., Cloughesy, T., Galldiks, N., Albert, N. L., Tonn, J. C., Avila, E., Fangusaro, J., Mirsky, D., Sahgal, A., Soffietti, R., Karschnia, P., Mehta, M., Kim, M. M., Boele, F., Huse, J. T., Nayak, L., Lim-Fat, M. J., le Rhun, E., …, & Chang, S. M. (2025). Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report. Neuro-Oncology, 27(9), 2209-2224. https://doi.org/10.1093/neuonc/noaf118
Vancouver
van den Bent MJ, Vogelbaum MA, Cloughesy T, Galldiks N, Albert NL, Tonn JC, et al. Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report. Neuro-Oncology. 2025;27(9):2209-2224. doi:10.1093/neuonc/noaf118
BibTeX
@article{vandenBent2025,
author = {van den Bent, Martin J and Vogelbaum, Michael A and Cloughesy, Tim and Galldiks, Norbert and Albert, Nathalie L and Tonn, Joerg-Christian and Avila, Edward and Fangusaro, Jason and Mirsky, David and Sahgal, Arjun and Soffietti, Ricardo and Karschnia, Philipp and Mehta, Minesh and Kim, Michelle M and Boele, Florien and Huse, Jason T and Nayak, Lakshmi and Lim-Fat, Mary Jane and le Rhun, Emilie and Desjardins, Annick and Lee, Eudocia Q and Chukwueke, Ugonma and Koekkoek, Johan A F and Mendoza, Tito and Loughan, Ashlee R and Budhu, Joshua A and Bakas, Spyridon and Huang, Raymond Y and Villanueva-Meyer, Javier E and Leone, Jose Pablo and Okada, Hideho and Reardon, David A and Bi, Wenya L and Wen, Patrick Y and Chang, Susan M},
title = {Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report},
journal = {Neuro-Oncology},
year = {2025},
volume = {27},
number = {9},
pages = {2209--2224},
doi = {10.1093/neuonc/noaf118}
}
EUVIMED